Nanochon develops medical implant technology focused on cartilage repair for patients with joint surface damage.
NANOCHON has raised $4.1M in total funding. The most recent round was Seed. The last funding was announced in January 2026.
NANOCHON's investors include Alumni Ventures, National Science Foundation, Creative Destruction Lab (CDL), cultivate(MD), Wilson Sonsini Goodrich & Rosati.
NANOCHON is headquartered in Washington, United States.
Nanochon develops medical implant technology focused on cartilage repair for patients with joint surface damage.
NANOCHON is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"NANOCHON — Funding & Investors." VCBacked, January 12, 2026, https://www.vcbacked.co/company/nanochon. Accessed October 26, 2026.
VCBacked. (2026). NANOCHON — Funding & Investors. Retrieved October 26, 2026, from https://www.vcbacked.co/company/nanochon
{{cite web |title=NANOCHON — Funding & Investors |url=https://www.vcbacked.co/company/nanochon |website=VCBacked |access-date=October 26, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated